Keith Michael Gottesdiener - Oct 8, 2024 Form 4 Insider Report for Prime Medicine, Inc. (PRME)

Role: President and Chief Executive Officer, Director
Signature: /s/ Karen Brown, attorney-in-fact
Stock symbol: PRME
Transactions as of: Oct 8, 2024
Transactions value $: $0
Form type: 4
Date filed: 10/10/2024, 04:29 PM
Previous filing: Jun 7, 2024
Next filing: Dec 9, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRME	Common Stock	Gift	$0	-227K	-81.87%	$0.00	50.2K	Oct 8, 2024	By Spouse	F1
transaction	PRME	Common Stock	Gift	$0	+227K	+49.84%	$0.00	682K	Oct 8, 2024	By Trust	F1, F2
holding	PRME	Common Stock						2.31M	Oct 8, 2024	Direct
holding	PRME	Common Stock						1.32M	Oct 8, 2024	By Trust	F3

Showing 1 to 4 of 4 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On October 8, 2024, for bona fide estate planning purposes, the Reporting Person's spouse transferred 226,925 shares of Issuer common stock to a family trust for no consideration.
F2	Shares held by a trust for which certain of the Reporting Person's family member is a trustee. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F3	Shares held by a trust for which the Reporting Person's spouse and certain of the Reporting Person's family member are co-trustees. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Remarks:

President and Chief Executive Officer